Jaguar Health
NASDAQ: JAGXSan Francisco, US · Founded 2013 · Delaware corporation · 1 known investors
Founders & leadership
Jaguar Health was founded in 2013 by Lisa Conte.
LC
Lisa ConteFounder
CL
Carol LizakExecutive
PC
Pravin ChaturvediExecutive
SK
Steven KingExecutive
JW
Jonathan WolinExecutive
SM
Serge MartinodExecutive
CT
Charles ThompsonExecutive
Board
JB
James BochnowskiBoard director
JM
John Micek, IIIBoard director
AJ
JS
Jonathan SiegelBoard director
GD
Greg DivisBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$194.1M disclosed across 42 rounds · 2013–2026
▶$2MraisedJul 2026 · 2 investors · PharmaceuticalsRule 506(b)
▶$2MraisedJul 2026 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Lisa ConteExecutive Officer, Director
- Carol LizakExecutive Officer
- Steven KingExecutive Officer
- Jonathan WolinExecutive Officer
- James BochnowskiDirector
- John Micek IIIDirector
- Anula JayasuriyaDirector
- Jonathan SiegelDirector
- Pravin ChaturvediExecutive Officer
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40.8MraisedJul 2026 · 1 investors · PharmaceuticalsRule 506(b)
▶$40.8MraisedJul 2026 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Lisa ConteExecutive Officer, Director
- Carol LizakExecutive Officer
- Steven KingExecutive Officer
- Jonathan WolinExecutive Officer
- James BochnowskiDirector
- John Micek IIIDirector
- Anula JayasuriyaDirector
- Jonathan SiegelDirector
- Pravin ChaturvediExecutive Officer
- Offering amount
- $40.8M
- Amount sold
- $40.8M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.8MraisedNov 2025 · PharmaceuticalsRule 506(b)
▶$10.8MraisedNov 2025 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Carol LizakExecutive Officer
- John Micek IIIDirector
- Jonathan WolinExecutive Officer
- Lisa ConteExecutive Officer, Director
- Anula JayasuriyaDirector
- Pravin ChaturvediExecutive Officer
- Jonathan SiegelDirector
- James BochnowskiDirector
- Steven KingExecutive Officer
- Offering amount
- $10.8M
- Amount sold
- $10.8M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedOct 2025 · 1 investors · PharmaceuticalsRule 506(b)
▶$1MraisedOct 2025 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan SiegelDirector
- Steven KingExecutive Officer
- James BochnowskiDirector
- Carol LizakExecutive Officer
- John Micek IIIDirector
- Lisa ConteExecutive Officer, Director
- Jonathan WolinExecutive Officer
- Pravin ChaturvediExecutive Officer
- Anula JayasuriyaDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.4MraisedSep 2025 · 15 investors · PharmaceuticalsRule 506(b)
▶$2.4MraisedSep 2025 · 15 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Lisa ConteExecutive Officer, Director
- Steven KingExecutive Officer
- Anula JayasuriyaDirector
- Pravin ChaturvediExecutive Officer
- Jonathan WolinExecutive Officer
- Carol LizakExecutive Officer
- James BochnowskiDirector
- John Micek IIIDirector
- Jonathan SiegelDirector
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMay 2025 · 3 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedMay 2025 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Carol LizakExecutive Officer
- Pravin ChaturvediExecutive Officer
- James BochnowskiDirector
- Lisa ConteExecutive Officer, Director
- John Micek IIIDirector
- Anula JayasuriyaDirector
- Steven KingExecutive Officer
- Jonathan SiegelDirector
- Jonathan WolinExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Sales commissions
- $190.9K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$60KraisedNov 2023 · 1 investors · PharmaceuticalsRule 506(b)
▶$60KraisedNov 2023 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Carol LizakExecutive Officer
- Lisa ConteExecutive Officer, Director, Promoter
- Jonathan B. SiegelDirector
- Jonathan WolinExecutive Officer
- James BochnowskiDirector
- John Micek IIIDirector
- Anula JayasuriyaDirector
- Steven KingExecutive Officer
- Offering amount
- $60K
- Amount sold
- $60K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedMay 2023 · 3 investors · PharmaceuticalsRule 506(b)
▶$1.8MraisedMay 2023 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anula JayasuriyaDirector
- Jonathan B. SiegelDirector
- John Micek IIIDirector
- Steven KingExecutive Officer
- James BochnowskiDirector
- Carol LizakExecutive Officer
- Lisa ConteExecutive Officer, Director, Promoter
- Jonathan WolinExecutive Officer
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Jaguar Health (JAGX) Investor update Summary | Quartrquartr.com · Aug 2026
Jaguar Health registers 41M shares for resale | JAGX IPO Registration (S-1)stocktitan.net · Jul 2026
Jaguar Health secures $40M equity line, $2M prefs | JAGX 8-K Filingstocktitan.net · Jun 2026Frequently asked questions
- Who founded Jaguar Health?
- Jaguar Health was founded by Lisa Conte in 2013.
- Who are Jaguar Health's investors?
- Jaguar Health's investors include DigitalDx Ventures.
- How much funding has Jaguar Health raised?
- Jaguar Health has disclosed $194.1M raised across 42 rounds.
- Where is Jaguar Health headquartered?
- Jaguar Health is headquartered in San Francisco, US.